MIPA-NOTA

Chengdu Pukang Biological Technology Co., Ltd. was established in 2008, located in the national Cross-strait science and technology industrial development park -- Chengdu Wenjiang District Strait Science and Technology Park, specializing in the long-term development of chronic disease polypeptide drugs.As a production, sales, research and development as one of the manufacturers.At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.Plan to build 12000 square meters of production base, according to GMP standard quality system management.In recent years, Pukang pharmaceutical has been audited more than ten times by well-known pharmaceutical enterprises at home and abroad, and has been recognized.

The main products of the company include high purity single molecule polyethylene glycol derivatives, long-acting drug side chains of polypeptides and their intermediates (including cimerlutide side chains, liraglutide side chains, insulin Degludec side chains, long-acting human growth hormone side chains, etc.), short peptide drug modified side chains (cimerlutide dipeptide, tetraceptides).

The company is cooperating with innovation Pharmaceutical company to build a long-term peptide drug research and development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of solutions for the development of long-term peptide drugs.Companies adhering to the "quality first, technology first" concept, to provide the best products and the best service for customers around the world.

Molecular Weight:539.5

Appearance:White to of-white powder

Application:Medical intermediate

Delivery Time:Customized

Package:inside:double PE bag  outside:paper drum

Port:Any port in China

Purity:≥95%

Storage:Store at 2-8℃

Transportation:CIF by air or DAP by courier, FOB, EX W Etc...

Chengdu Pukang Biological Technology Co., Ltd. was established in 2008, located in the national Cross-strait science and technology industrial development park -- Chengdu Wenjiang District Strait Science and Technology Park, specializing in the long-term development of chronic disease polypeptide drugs.As a production, sales, research and development as one of the manufacturers.At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.Plan to build 12000 square meters of production base, according to GMP standard quality system management.In recent years, Pukang pharmaceutical has been audited more than ten times by well-known pharmaceutical enterprises at home and abroad, and has been recognized.

The main products of the company include high purity single molecule polyethylene glycol derivatives, long-acting drug side chains of polypeptides and their intermediates (including cimerlutide side chains, liraglutide side chains, insulin Degludec side chains, long-acting human growth hormone side chains, etc.), short peptide drug modified side chains (cimerlutide dipeptide, tetraceptides).

The company is cooperating with innovation Pharmaceutical company to build a long-term peptide drug research and development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of solutions for the development of long-term peptide drugs.Companies adhering to the "quality first, technology first" concept, to provide the best products and the best service for customers around the world.